|
|
|
BTCY's EPS from Cont. Operations Growth by Quarter and Year
Biotricity Inc 's EPS from Cont. Operations results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
EPS from Cont. Operations Growth Y/Y▼
|
EPS from Cont. Operations Growth Y/Y▼
|
| BTCY EPS from Cont. Operations (in $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
| 4th Quarter |
March |
-
|
-0.07
|
-0.09
|
-0.15
|
| 3rd Quarter |
December |
-0.05
|
-0.34
|
-0.09
|
-0.26
|
| 2nd Quarter |
September |
-0.07
|
-0.07
|
-0.10
|
-0.15
|
| 1st Quarter |
June |
-0.49
|
-0.09
|
-0.11
|
-0.15
|
| FY |
|
-0.61
|
-0.57
|
-0.39
|
-0.71
|
| BTCY EPS from Cont. Operations third quarter 2025 Y/Y Growth Comment |
Biotricity Inc in the third quarter 2025 recorded EPS loss from Cont. Operations of $ -0.05 .
According to the results reported in the third quarter 2025, Biotricity Inc achieved the best EPS from Cont. Operations growth in Medical Equipment & Supplies industry. While Biotricity Inc ' s EPS from Cont. Operations no change of 0% ranks overall at the positon no. in the third quarter 2025.
|
| BTCY EPS from Cont. Operations ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
March |
- |
- |
- |
- |
| 3rd Quarter |
December |
- |
- |
- |
- |
| 2nd Quarter |
September |
- |
- |
- |
- |
| 1st Quarter |
June |
- |
- |
- |
- |
| FY |
|
- |
- |
- |
- |
BTCY EPS from Cont. Operations (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
March |
- |
- |
- |
- |
| 3rd Quarter |
December |
- |
- |
- |
- |
| 2nd Quarter |
September |
- |
- |
- |
- |
| 1st Quarter |
June |
- |
- |
- |
- |
| FY (Year on Year) |
|
- |
- |
- |
- |
| EPS from Cont. Operations Y/Y Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
|
|
| EPS from Cont. Operations Y/Y Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
|
| EPS from Cont. Operations by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Biotricity Inc 's Q/Q EPS from Cont. Operations Growth
| EPS from Cont. Operations Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| BTCY's III. Quarter Q/Q EPS from Cont. Operations Comment |
Despite the fact, that Biotricity Inc in the III. Quarter 2025 revealed EPS loss from Cont. Operations of $ -0.05 , it should be mentioned, that those numbers are recovery in contrast to the -0.07 in the second quarter.
Within Medical Equipment & Supplies industry Biotricity Inc achieved highest sequential EPS from Cont. Operations growth. While Biotricity Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is . |
|
|
|
| EPS from Cont. Operations Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| BTCY's III. Quarter Q/Q EPS from Cont. Operations Comment |
Despite the fact, that Biotricity Inc in the III. Quarter 2025 revealed EPS loss from Cont. Operations of $ -0.05 , it should be mentioned, that those numbers are recovery in contrast to the -0.07 in the second quarter.
Within Medical Equipment & Supplies industry Biotricity Inc achieved highest sequential EPS from Cont. Operations growth. While Biotricity Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is . |
|
Biotricity Inc 's 12 Months EPS from Cont. Operations Growth Year on Year
EPS from Cont. Operations TTM Growth |
12 Months Ending
(Dec 31 2024) |
12 Months Ending
(Sep 30 2024) |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
| Cumulative EPS from Cont. Operations 12 Months Ending |
$ -0.68 |
$ -0.97 |
$ -0.97 |
$ -0.57 |
$ -0.59 |
| Y / Y EPS from Cont. Operations Growth (TTM) |
- |
- |
- |
- |
- |
| Year on Year EPS from Cont. Operations Growth Overall
Ranking |
# |
# |
# |
# |
# |
| Seqeuential EPS from Cont. Operations Change (TTM) |
- |
- |
- |
- |
- |
| Seq. EPS from Cont. Operations Growth (TTM) Overall
Ranking |
# |
# |
# |
# |
# |
| Cumulative EPS from Cont. Operations growth Comment |
Biotricity Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Dec 31 2024 period.
Biotricity Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. . |
|
|
| EPS from Cont. Operations TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| EPS from Cont. Operations TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# |
| Sector |
# |
| S&P 500 |
# |
|
| Cumulative EPS from Cont. Operations growth
Comment |
Biotricity Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Dec 31 2024 period.
Biotricity Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. . |
| EPS from Cont. Operations TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| EPS from Cont. Operations TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# |
| Sector |
# |
| S&P 500 |
# |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
